Back to Search
Start Over
P27, SKP2, and extra-cellular signal-related kinase signalling in human salivary gland mucoepidermoid carcinoma.
- Source :
-
Oral oncology [Oral Oncol] 2006 Nov; Vol. 42 (10), pp. 1005-10. Date of Electronic Publication: 2006 Jun 06. - Publication Year :
- 2006
-
Abstract
- Extra-cellular signal-related kinase (ERK) can modulate P27 in several ways. ERK is phosphorylated in a subset of salivary gland mucoepidermoid carcinoma (MEC). We determined immunohistochemical expression of P27, SKP2, cyclin A, Ki67, phospho-RB, and phospho-ERK in 43 MEC. SKP2 correlated with tumour size, microscopic grade, and a worse prognosis. Cyclin A and Ki67 also predicted prognosis, and were correlated with SKP2. P27 did not predict prognosis. P27 had no inverse relationship with SKP2, and correlated with neither Ki67 nor cyclin A. Instead, P27 high expressers had higher levels of phospho-ERK and phospho-RB. When highly expressed, P27 co-localized with cyclin D1 in the nuclei. Relationships of P27 with ERK and RB and its nuclear co-localization with cyclin D1 favour the hypothesis that P27 is in complexes with cyclin D1. This may explain why P27 in contrast to SKP2 and cyclin A does not correlate with tumour cell proliferation and prognosis.
- Subjects :
- Carcinoma, Mucoepidermoid pathology
Cell Proliferation
Cyclin D
Cyclins metabolism
Disease-Free Survival
Extracellular Signal-Regulated MAP Kinases metabolism
Female
Head and Neck Neoplasms pathology
Humans
Male
Middle Aged
Prognosis
Proliferating Cell Nuclear Antigen metabolism
S-Phase Kinase-Associated Proteins metabolism
Salivary Gland Neoplasms pathology
Biomarkers, Tumor metabolism
Carcinoma, Mucoepidermoid metabolism
Head and Neck Neoplasms metabolism
Neoplasm Proteins metabolism
Salivary Gland Neoplasms metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1368-8375
- Volume :
- 42
- Issue :
- 10
- Database :
- MEDLINE
- Journal :
- Oral oncology
- Publication Type :
- Academic Journal
- Accession number :
- 16757206
- Full Text :
- https://doi.org/10.1016/j.oraloncology.2005.12.022